Cargando…

Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40(+) monocyte differentiation

Adaptive immunity is critical for disease progression and modulates T cell (TC) and antigen-presenting cell (APC) functions. Three signals were initially proposed for adaptive immune activation: signal 1 antigen recognition, signal 2 co-stimulation or co-inhibition, and signal 3 cytokine stimulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Jin, Fang, Pu, Saredy, Jason, Xi, Hang, Ramon, Cueto, Yang, William, Choi, Eric T., Ji, Yong, Mao, Wei, Yang, Xiaofeng, Wang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525309/ https://www.ncbi.nlm.nih.gov/pubmed/28738836 http://dx.doi.org/10.1186/s13045-017-0504-1

Ejemplares similares

Innate-adaptive immunity interplay and redox regulation in immune response
por: Sun, Lizhe, et al.
Publicado: (2020)

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
por: Deng, Juan, et al.
Publicado: (2019)

The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection
por: Wang, Ping-Huai, et al.
Publicado: (2021)

CD40/CD40 LIGAND INTERACTIONS IN IMMUNE RESPONSES AND PULMONARY IMMUNITY
por: KAWABE, TSUTOMU, et al.
Publicado: (2011)

Induction of potent systemic anti-melanoma immunity through intratumoral CD40 activation and checkpoint blockade
por: Singh, Manisha, et al.
Publicado: (2015)

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40
Publicado: (1993)

Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
por: Digomann, David, et al.
Publicado: (2023)

Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance
por: Yang, Qian, et al.
Publicado: (2021)

Immunological Feature and Transcriptional Signaling of Ly6C Monocyte Subsets From Transcriptome Analysis in Control and Hyperhomocysteinemic Mice
por: Yang, Pingping, et al.
Publicado: (2021)

CD40-CD40L Interaction in Immunity Against Protozoan Infections
por: Chamekh, Mustapha
Publicado: (2007)

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells
por: Sadeghlar, Farsaneh, et al.
Publicado: (2020)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
por: Yan, Chi, et al.
Publicado: (2021)

The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2021)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
por: Chen, Peixin, et al.
Publicado: (2021)

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint
por: Ding, Zhuang, et al.
Publicado: (2021)

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis
por: Fadul, Camilo E., et al.
Publicado: (2021)

The CD83 Molecule – An Important Immune Checkpoint
por: Grosche, Linda, et al.
Publicado: (2020)

Molecular cloning of duck CD40 and its immune function research
por: Zhang, Rujuan, et al.
Publicado: (2021)

Multiple effects of CD40–CD40L axis in immunity against infection and cancer
por: Ara, Anjuman, et al.
Publicado: (2018)

Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease
por: Wang, Xianwei, et al.
Publicado: (2023)

Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy
por: Baumann, Daniel, et al.
Publicado: (2020)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis
por: Deng, Chuiwen, et al.
Publicado: (2020)

On the mechanism of anti-CD39 immune checkpoint therapy
por: Allard, David, et al.
Publicado: (2020)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors
por: Zhong, Hui, et al.
Publicado: (2020)

Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor
por: Chen, Yang, et al.
Publicado: (2021)

Adaptive Immune Response Signaling Is Suppressed in Ly6C(high) Monocyte but Upregulated in Monocyte Subsets of ApoE (-/-) Mice — Functional Implication in Atherosclerosis
por: Yang, Pingping, et al.
Publicado: (2021)

Regulation of Monocyte-Macrophage Responses in Cirrhosis—Role of Innate Immune Programming and Checkpoint Receptors
por: Riva, Antonio, et al.
Publicado: (2019)

Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory Pathways
por: Voynova, Elisaveta, et al.
Publicado: (2018)

The Role of NcRNAs to Regulate Immune Checkpoints in Cancer
por: Jiang, Yicun, et al.
Publicado: (2022)

Humoral immune responses in CD40 ligand-deficient mice
Publicado: (1994)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
por: Zhao, Jun, et al.
Publicado: (2019)

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200
por: Moon, Sun Young, et al.
Publicado: (2023)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma
por: Peng, Lijun, et al.
Publicado: (2022)

Correction: On the mechanism of anti-CD39 immune checkpoint therapy
Publicado: (2020)

Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
por: Lian, Shu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ug3g0mb5o7qn4grsq16vlmlh82